Alaunos Therapeutics (TCRT) Other Working Capital Changes (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Other Working Capital Changes of -$40000.0 for Q1 2026, down 128.57% on a YoY basis from $140000.0 in Q1 2025, and up 80.2% quarter-over-quarter from -$202000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Other Working Capital Changes for 18 years, with the latest figure at -$40000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 128.57% year-over-year to -$40000.0; the trailing twelve-month figure through Mar 2026 stood at -$530000.0 (down 476.09% YoY), and the FY2025 full-year result was -$350000.0, up 35.06% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$40000.0, up from -$202000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $927000.0 in Q4 2023, with the low at -$344000.0 in Q3 2024.
- Historically, Other Working Capital Changes has averaged $33200.0 across 5 years, with a median of -$122000.0 in 2025.
- The largest YoY upside for Other Working Capital Changes was 209.22% in 2024 against a maximum downside of 526.53% in 2024.
- Alaunos Therapeutics' Other Working Capital Changes stood at $177000.0 in 2022, then jumped by 423.73% to $927000.0 in 2023, then plunged by 122.44% to -$208000.0 in 2024, then advanced by 2.88% to -$202000.0 in 2025, then jumped by 80.2% to -$40000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$40000.0 (Q1 2026), -$202000.0 (Q4 2025), and -$166000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | -202,000.00 |
| Dec 31, 2025 | -202,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | -122,000.00 |
| Jun 30, 2025 | -122,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -344,000.00 |
| Sep 30, 2024 | -344,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Mar 31, 2024 | -307,000.00 |
| Mar 31, 2024 | -307,000.00 |
| Dec 31, 2023 | 927,000.00 |
| Dec 31, 2023 | 927,000.00 |